- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05558020
Feasibility of Constant Work Rate Testing to Detect Exercise-induced Laryngeal Obstruction
TITLE Feasibility of constant work rate testing to detect exercise-induced laryngeal obstruction
DESIGN Prospective observational pilot study
AIMS To investigate if constant work rate testing at different work rates will sufficiently induce detectable exercise-induced laryngeal obstruction (EILO) using CLE.
POPULATION Adult patients with EILO
DURATION 01.09.2022 - 30.06.2023
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Emil Walsted, MD, PhD
- Phone Number: +4530338750
- Email: emil.ingerslev.walsted@regionh.dk
Study Contact Backup
- Name: Jens T Pedersen, BSc
- Phone Number: +4529422843
- Email: jens.thougaard.pedersen@gmail.com
Study Locations
-
-
Region Hovedstaden
-
København NV, Region Hovedstaden, Denmark, 2400
- Recruiting
- Bispebjerg Hospital
-
Contact:
- Emil Ingerslev Walsted, MD, PhD
- Phone Number: +4530338750
- Email: emil.ingerslev.walsted@regionh.dk
-
Contact:
- Jens Thougaard Pedersen, B.Sc
- Phone Number: +4529422843
- Email: jens.thougaard.pedersen@regionh.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Individuals referred to CLE testing at the asthma service at Bispebjerg Hospital in Copenhagen, Denmark, for the investigation of exercise-related respiratory symptoms, will be offered to participate in the present study in addition to the standard-of-care incremental CLE test.
Al patients will be evaluated during the visit to the asthma service at Bispebjerg Hospital to ensure they are clinically fit for exercise testing.
Description
Inclusion Criteria:
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 or above with a clinical suspicion of having EILO.
- Individuals with concurrent asthma can participate in the study provided that their asthma is well-controlled, determined by a negative bronchoprovocation test.
Exclusion Criteria:
- No EILO found in Clinical standard-of-care CLE test
- Not able to complete the exercise test for other reasons than breathlessness or leg fatigue (e.g. injury, disease or disability preventing cycling to maximal exertion).
- Comorbidities other than asthma, which, judged by the investigator, might confound the test results or pose a medical risk to the patient (e.g. cardiac disease, exercise-induced anaphylaxis).
- Current smokers (< 6 months of stopping) or individuals with a significant smoking history (>10 pack years).
- Pregnancy.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
prevalence and degree of glottic or supraglottic collapse in EILO patients
Time Frame: Changes from baseline during the procedure and immediately after cessation of the exercise test.
|
Laryngoscopic detection of supraglottic or a glottic obstruction of the same severity as observed during incremental testing, during a submaximal constant work rate exercise test (70 %, 80 % and 90 %) using a visual grade scale (0-3, with 0 reflecting no obstruction, and 3 being the most severe degree of obstruction).
|
Changes from baseline during the procedure and immediately after cessation of the exercise test.
|
Time of onset of the laryngeal obstruction
Time Frame: A time of onset determined during the procedures
|
A specific point in time where observed laryngeal obstruction is first discernible will be determined during the evaluation of the laryngoscopic videos. This is to descriptively quantify this outcome. |
A time of onset determined during the procedures
|
Observed duration of the laryngeal obstruction
Time Frame: Duration measured in seconds during the procedures
|
The investigators will further evaluate the laryngoscopic videos and determine the duration of the participant's laryngeal obstruction.
This duration is defined as the time period from the time of onset during submaximal exercise, until remission of the observed obstruction or end of the test.
|
Duration measured in seconds during the procedures
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient reported symptom score: Dyspnoea-12
Time Frame: At baseline
|
The patients will fill out the Dyspnoea-12 questionnaire before the first exercise test The questionnaire consists of 12 questions regarding dyspnoea.
This is a descriptive measure
|
At baseline
|
Patient reported symptom scores: Nijmegen
Time Frame: At baseline
|
The participants will fill out the Nijmegen questionnaire before the first exercise test The questionnaire consists of 16 questions, with answers ranging from "never" to "very often". A score is calculated from these answers. A higher score means that it is more likely that the participant suffers from hyperventilation syndrome. This is a descriptive measure |
At baseline
|
Patient reported symptom scores: Multidimensional Dyspnoea Profile (MDP).
Time Frame: At baseline
|
The patients will fill out the Multidimensional Dyspnoea Profile (MDP) questionnaire before the first exercise test This profile consists of questions regarding both affective and sensory components of dyspnoea. This is a descriptive measure |
At baseline
|
Modified borg dyspnoea during exercise
Time Frame: At baseline and at one minute intervals during the CLE tests (up to 60 minutes)
|
Minimum score: 0 Maximum score: 10 The participant will be asked to rate dyspnoea at baseline and during the CLE tests at 1 minute intervals. The investigators will compare the scores between the incremental CLE tests and the constant work rate CLE tests. |
At baseline and at one minute intervals during the CLE tests (up to 60 minutes)
|
Leg fatigue scores during exercise
Time Frame: At baseline and at one minute intervals during the CLE tests (up to 60 minutes)
|
Minimum score: 0 Maximum score: 10 The participant will be asked to rate leg fatigue at baseline and during the CLE tests at 1 minute intervals. The investigators will compare the scores between the incremental CLE tests and the constant work rate CLE tests. |
At baseline and at one minute intervals during the CLE tests (up to 60 minutes)
|
Rate of perceived exertion (RPE) scores during exercise
Time Frame: At baseline and at one minute intervals during the CLE tests (up to 60 minutes)
|
Minimum score: 0 Maximum score: 10 The participant will be asked to evaluate their rate of perceived exertion at baseline and during the CLE tests at 1 minute intervals. The investigators will compare the scores between the incremental CLE tests and the constant work rate CLE tests. |
At baseline and at one minute intervals during the CLE tests (up to 60 minutes)
|
Inter-rater agreement of the prevalence and degree of glottic or supraglottic collapse in EILO patients
Time Frame: During data analysis (month 1).
|
After obtaining laryngoscopic video data, the investigators will evaluate the severity of laryngeal obstruction using a visual grade scale (0-3). From these gradings we will calculate inter-rater agreement values (weighted kappa). |
During data analysis (month 1).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- H-20057391
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise-induced Laryngeal Obstruction (EILO)
-
Haukeland University HospitalCompletedExercise Induced Laryngeal Obstruction (EILO)Norway
-
Haukeland University HospitalRecruiting
-
Liverpool University Hospitals NHS Foundation TrustRecruitingExercise-Induced Laryngeal ObstructionUnited Kingdom
-
VID Specialized UniversityNorwegian School of Sport SciencesCompletedExercise Induced Laryngeal Obstruction (EILO)Norway
-
University of BernRecruitingCough | Asthma | Dysfunctional Breathing | Wheezing | Exercise Induced Bronchospasm | Inspiratory Laryngeal ObstructionSwitzerland, Austria
-
Appalachian State UniversityDole Food CompanyCompletedExercise-induced Inflammation | Exercise-induced Oxidative Stress | Exercise-induced Immune DysfunctionUnited States
-
Norwegian University of Science and TechnologyKlinikk for allergi og luftveissykdommerCompletedExercise Induced BronchoconstrictionNorway
-
University of SaskatchewanRecruiting
-
St Mary's University CollegeNot yet recruitingExercise Induced Muscle Damage
-
Universidad Autonoma de Ciudad JuarezCompletedExercise-induced Oxidative Stress
Clinical Trials on Continuous laryngoscopy during exercise (CLE), incremental exercise protocol
-
Helsinki University Central HospitalWithdrawnLarynx | Obstruction | Vocal Cord DysfunctionFinland
-
Liverpool University Hospitals NHS Foundation TrustRecruitingExercise-Induced Laryngeal ObstructionUnited Kingdom